{"meta":{"query_hash":"6241b1b2ec45","filters":{"venue":"Therapeutic Advances in Chronic Disease"},"cohort_total":31,"direct_labels_cover":0,"predictions_cover":31,"exported":31,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6241b1b2ec45","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Chronic+Disease"},"results":[{"id":"W1992043927","doi":"10.1177/2040622313485275","title":"Prevention of infection caused by immunosuppressive drugs in gastroenterology","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Medical Research Council; Wellcome Trust","keywords":"Medicine; Disease; Autoimmune pancreatitis; Inflammatory bowel disease; Intensive care medicine; Autoimmune hepatitis; Immunosuppression; Immune system; Immunology; Transplantation; Pancreatitis; Internal medicine","score_opus":0.009964163381399806,"score_gpt":0.30417787711842487,"score_spread":0.29421371373702504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992043927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027353212,0.9351472,0.0038105852,0.012254861,0.0013034289,0.000057650108,0.000032290707,0.00007929446,0.019961528],"genre_scores_gemma":[0.20492306,0.7676688,0.012731969,0.0036350635,0.0039710486,0.000054541033,0.00006198158,0.000018251176,0.0069353115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996635,0.00013536037,0.000033445718,0.000018062616,0.00012105181,0.000028509752],"domain_scores_gemma":[0.9995648,0.00016446655,0.000110864574,0.000022440594,0.000072784955,0.000064583786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079440867,0.0002845988,0.000452483,0.000630463,0.00027442983,0.00059454364,0.00022934767,0.0005988945,0.0022157445],"category_scores_gemma":[0.0007764742,0.000092077884,0.00026434596,0.00039929966,0.00034381702,0.0005626439,0.00035060217,0.000896331,0.0006278884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027480643,0.00060705876,0.009434795,0.0029552293,0.000090440495,0.0013306907,0.00018772008,0.00014315873,0.008196943,0.0061034644,0.014162738,0.9565129],"study_design_scores_gemma":[0.00025808974,0.0029480269,0.07182207,0.005157625,0.00044959996,0.021460189,0.0005100055,0.0004158316,0.014684251,0.009284486,0.8729612,0.000048549664],"about_ca_topic_score_codex":0.00021336856,"about_ca_topic_score_gemma":0.0006478464,"teacher_disagreement_score":0.0022157445,"about_ca_system_score_codex":0.00025367705,"about_ca_system_score_gemma":0.0006719144,"threshold_uncertainty_score":0.007412374},"labels":[],"label_agreement":null},{"id":"W2016703957","doi":"10.1177/2040622310376137","title":"Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Medicine; Pharmacotherapy; Comorbidity; Cohort study; Confounding; MEDLINE; Cohort; Osteoporosis; Physical therapy; Intensive care medicine; Internal medicine","score_opus":0.051724685187059395,"score_gpt":0.5056621096128067,"score_spread":0.45393742442574725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016703957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015019971,0.940181,0.011019558,0.015468917,0.0025294009,0.020961594,0.0050613717,0.00026654985,0.0030096904],"genre_scores_gemma":[0.022831883,0.8390903,0.0786826,0.013845021,0.0009800405,0.04017616,0.0027839765,0.00012470172,0.0014853171],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.90914667,0.038792074,0.03520688,0.004041098,0.011731249,0.0010821312],"domain_scores_gemma":[0.8292488,0.11318411,0.026359146,0.0048848814,0.024634417,0.0016885314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10194417,0.0047280774,0.011729816,0.03646591,0.001351933,0.0064186924,0.0056798826,0.0050315876,0.010860556],"category_scores_gemma":[0.2624755,0.0030915933,0.01252825,0.020588305,0.0020617652,0.008967417,0.0045134593,0.0032140617,0.0016343326],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015080294,0.000031048796,0.0010784932,0.90946996,0.011925184,0.0001437149,0.00041147866,0.0002467936,0.00018493262,0.0010530389,0.007531695,0.06777282],"study_design_scores_gemma":[0.00031491378,0.00006743222,0.0012499603,0.9392105,0.03148385,0.00016298794,0.00024555513,0.00020998015,0.00020630423,0.001851604,0.024935327,0.00006167009],"about_ca_topic_score_codex":0.010752749,"about_ca_topic_score_gemma":0.030640293,"teacher_disagreement_score":0.10194417,"about_ca_system_score_codex":0.008459831,"about_ca_system_score_gemma":0.033744,"threshold_uncertainty_score":0.5391388},"labels":[],"label_agreement":null},{"id":"W2054018944","doi":"10.1177/2040622315582325","title":"Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bedaquiline; Medicine; Culture conversion; Tuberculosis; Pharmacology; Regimen; Multiple drug resistance; Internal medicine; Drug resistance; Sputum; Mycobacterium tuberculosis; Microbiology; Pathology","score_opus":0.13065364132914237,"score_gpt":0.4721214263435056,"score_spread":0.34146778501436326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054018944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007068693,0.9774712,0.00009305787,0.019695006,0.00074320135,0.0000069371295,0.00004865588,0.000010557532,0.0012244745],"genre_scores_gemma":[0.011517022,0.9708555,0.00051836064,0.012626875,0.0030389412,0.000015167827,0.00009899546,0.000015667374,0.0013134606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860954,0.00063571765,0.0002773748,0.000089138404,0.0003329047,0.000055322333],"domain_scores_gemma":[0.99310523,0.0044178264,0.0009773513,0.0002121671,0.0010051818,0.0002821129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004701977,0.0003598783,0.001315998,0.0016056967,0.00036481916,0.0015006656,0.00067709934,0.0013469465,0.0063024377],"category_scores_gemma":[0.008799336,0.0002087499,0.0010933658,0.0016897017,0.0011222963,0.0044014854,0.00077681727,0.0021098284,0.00177281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078040996,0.000060670118,0.0010688192,0.03015453,0.00044291036,0.00076781784,0.0004350648,0.0001101483,0.0012232622,0.0053808247,0.07905173,0.88052386],"study_design_scores_gemma":[0.00047544274,0.0012544084,0.0060263765,0.041145455,0.0014296429,0.004362357,0.0016716474,0.00023480925,0.00072486955,0.011677852,0.93086165,0.00013553645],"about_ca_topic_score_codex":0.0009578294,"about_ca_topic_score_gemma":0.0044185966,"teacher_disagreement_score":0.0063024377,"about_ca_system_score_codex":0.00086041185,"about_ca_system_score_gemma":0.0015904118,"threshold_uncertainty_score":0.0248667},"labels":[],"label_agreement":null},{"id":"W2157692976","doi":"10.1177/2040622315579063","title":"Optimizing the use of thiopurines in inflammatory bowel disease","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Inflammatory bowel disease; Allopurinol; Adverse effect; Intensive care medicine; Disease; Pharmacology; Therapeutic drug monitoring; Bioinformatics; Internal medicine; Drug","score_opus":0.09126696932768238,"score_gpt":0.3969826641992717,"score_spread":0.30571569487158934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157692976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012361274,0.99877626,0.00006847305,0.00023899943,0.000097387136,0.0000030091499,0.000011155627,0.0000038526136,0.0006772848],"genre_scores_gemma":[0.00071521784,0.99864525,0.00014463768,0.0001403289,0.00009859239,0.0000033339413,0.00001690506,8.561085e-7,0.00023490563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977404,0.000050569957,0.00005084604,0.000031111573,0.00007721426,0.000016216505],"domain_scores_gemma":[0.99971026,0.00014361132,0.00005708085,0.0000071214454,0.00006707167,0.000014798439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048655563,0.00049963983,0.00088476477,0.001930327,0.00019828608,0.00068755,0.0005231971,0.00082576607,0.0028251612],"category_scores_gemma":[0.0008831885,0.00018384593,0.00050103717,0.0015241688,0.00027440523,0.0009253346,0.00048630984,0.0010883741,0.001105909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006946701,0.00006038208,0.00024129578,0.024222305,0.00010841227,0.0002077251,0.00006609247,0.00025496536,0.0010933271,0.0024319538,0.016996607,0.9542475],"study_design_scores_gemma":[0.000025074181,0.00010620727,0.0011863802,0.010077497,0.00021115615,0.0021759132,0.000083302635,0.00011055284,0.0005596962,0.0017784581,0.9836686,0.000017202838],"about_ca_topic_score_codex":0.0007691665,"about_ca_topic_score_gemma":0.001484405,"teacher_disagreement_score":0.0028251612,"about_ca_system_score_codex":0.00041294494,"about_ca_system_score_gemma":0.0007692457,"threshold_uncertainty_score":0.009451151},"labels":[],"label_agreement":null},{"id":"W2167828574","doi":"10.1177/2040622313492810","title":"Teriflunomide in relapsing multiple sclerosis: therapeutic utility","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Discontinuation; Adverse effect; Glatiramer acetate; Dimethyl fumarate; Oncology; Intensive care medicine; Internal medicine; Fingolimod; Immunology","score_opus":0.07470561988529514,"score_gpt":0.34655940101886296,"score_spread":0.27185378113356784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167828574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03816681,0.95157146,0.00043081408,0.0015945694,0.00010743914,0.00005086933,0.00008875136,0.000023933624,0.007965365],"genre_scores_gemma":[0.3153865,0.6802259,0.0012307569,0.00093585433,0.0005896536,0.00004976011,0.00012411879,0.000006154644,0.0014512445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998161,0.00008749714,0.000024602085,0.000017974158,0.000036472393,0.00001736298],"domain_scores_gemma":[0.99947363,0.00027037947,0.00013285648,0.000021284848,0.00005026032,0.00005164532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010892546,0.0002851575,0.00068465073,0.000882706,0.00017451703,0.00060747407,0.0002797137,0.0005918398,0.0019129306],"category_scores_gemma":[0.00076389266,0.00007554046,0.0002962623,0.0007701827,0.00036714616,0.00047309563,0.00021742684,0.0007900523,0.00041136018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027923528,0.0006928849,0.0027328678,0.0039326022,0.00020783435,0.0012983994,0.0001186265,0.0003802006,0.01835758,0.0016115159,0.0028852397,0.9649899],"study_design_scores_gemma":[0.009695067,0.055387292,0.08811349,0.010617665,0.0031603982,0.023653952,0.00082137453,0.0021410524,0.07696274,0.008999192,0.72030526,0.00014251002],"about_ca_topic_score_codex":0.00043203146,"about_ca_topic_score_gemma":0.0012543584,"teacher_disagreement_score":0.0019129306,"about_ca_system_score_codex":0.00027207498,"about_ca_system_score_gemma":0.0003205775,"threshold_uncertainty_score":0.0063993335},"labels":[],"label_agreement":null},{"id":"W2340805753","doi":"10.1177/2040622315617354","title":"Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Fingolimod; Medicine; Tolerability; Pharmacology; Multiple sclerosis; Adverse effect; Oncology; Immunology","score_opus":0.03232524596225401,"score_gpt":0.3212368205691443,"score_spread":0.2889115746068903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340805753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26607266,0.69784737,0.009303025,0.0056411945,0.00059024204,0.00020927422,0.00060764805,0.0009474205,0.018781118],"genre_scores_gemma":[0.60251594,0.36734065,0.008196275,0.0026764248,0.001020505,0.00016144654,0.00074921077,0.00006186084,0.017277649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999596,0.0000054926113,0.0000037130644,0.000011926762,0.000013132094,0.0000061472106],"domain_scores_gemma":[0.9999603,0.0000064886303,0.0000135012,0.0000017354203,0.0000066860453,0.000011269126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020748864,0.0002685266,0.00029420276,0.00041088162,0.00012783888,0.00028272677,0.000200379,0.00037582158,0.0021393714],"category_scores_gemma":[0.00013167321,0.00009226615,0.00018769092,0.00019945433,0.00022461802,0.0003754762,0.0001855986,0.0007812719,0.0004935053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014462665,0.000465282,0.0006779007,0.0016560763,0.000054936645,0.0008061744,0.00007440047,0.0003622259,0.26638234,0.0025370065,0.006391341,0.719146],"study_design_scores_gemma":[0.0027863935,0.017452179,0.02606663,0.0005675332,0.0005558199,0.016533092,0.00010264794,0.00388504,0.27838433,0.0052594948,0.64830506,0.00010175213],"about_ca_topic_score_codex":0.00026093767,"about_ca_topic_score_gemma":0.00051367166,"teacher_disagreement_score":0.0021393714,"about_ca_system_score_codex":0.0001972341,"about_ca_system_score_gemma":0.00023939497,"threshold_uncertainty_score":0.007156849},"labels":[],"label_agreement":null},{"id":"W2404889380","doi":"10.1177/2040622315627805","title":"The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Treatment of Major Depression","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Distress; Mood; Psychiatry; Mood disorders; Major depressive disorder; Clinical psychology; Specifier; Anxiety","score_opus":0.008690885963709304,"score_gpt":0.30698680910607956,"score_spread":0.29829592314237025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404889380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811906,0.00026392375,0.000093477625,0.00004790744,0.000006248555,0.000060194754,0.0011077345,0.000002844995,0.00029855984],"genre_scores_gemma":[0.9979882,0.000107705586,0.00025444737,0.000022877954,0.000008577802,0.00006241135,0.0014791685,0.0000013742306,0.000075239615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986358,0.00042321061,0.00031856168,0.00018193835,0.00034696618,0.000093442046],"domain_scores_gemma":[0.99728405,0.00043647308,0.0016443725,0.00010708257,0.0002972338,0.00023070132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002308099,0.00023404053,0.00039905784,0.0010571239,0.0002491919,0.0004922788,0.00043613501,0.00037198642,0.00064218004],"category_scores_gemma":[0.00517244,0.00021305264,0.0005094973,0.001066022,0.00020513125,0.00036714846,0.0008435199,0.00045791073,0.0001134434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008070681,0.00003029246,0.99836856,0.000018994757,0.000056593384,0.000014565354,0.000098534896,0.000017638791,0.00006192534,0.0000073004194,0.00013285191,0.0011120903],"study_design_scores_gemma":[0.0000060074885,0.00003749367,0.99973327,0.000004156653,0.000012511062,0.00004526518,0.00007552559,0.0000346818,0.000008652203,0.000004386756,0.000036946476,0.0000010677225],"about_ca_topic_score_codex":0.0036921673,"about_ca_topic_score_gemma":0.006624744,"teacher_disagreement_score":0.0036921673,"about_ca_system_score_codex":0.00028480781,"about_ca_system_score_gemma":0.00031307334,"threshold_uncertainty_score":0.012206554},"labels":[],"label_agreement":null},{"id":"W2414555042","doi":"10.1177/2040622315608648","title":"The diagnosis and treatment of chronic migraine: the case for daily scheduled opioid treatment in chronic headache","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic Migraine; Praise; Headaches; Opium; Chronic pain; Migraine; Pain medicine; Psychiatry; Psychology; Psychotherapist; History","score_opus":0.06133432041768011,"score_gpt":0.37809112161359437,"score_spread":0.31675680119591426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414555042","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020256087,0.11190011,0.0012998919,0.8686608,0.011056111,0.000030037061,0.000019755224,0.000022046155,0.004985635],"genre_scores_gemma":[0.08456463,0.21923734,0.013348183,0.51452154,0.16312681,0.00023207748,0.00007878145,0.000114312905,0.004776272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99242085,0.0027665386,0.0010003174,0.0008832384,0.0020033203,0.0009258652],"domain_scores_gemma":[0.98049486,0.011721245,0.0017328825,0.0007460686,0.002422925,0.0028820608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008591133,0.0009579106,0.0019004551,0.0023056956,0.0048461133,0.0049614306,0.0028189204,0.022463875,0.003202692],"category_scores_gemma":[0.026002029,0.0009807509,0.0019751762,0.0016327447,0.013940548,0.017604109,0.0044065095,0.03397943,0.001378811],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029234076,0.0002961167,0.009368599,0.0036609182,0.00016449273,0.17291665,0.012169484,0.00035999477,0.0009469957,0.07933033,0.52266294,0.19783127],"study_design_scores_gemma":[0.00012794923,0.00018172797,0.003165785,0.011844679,0.00013722356,0.4153303,0.012105477,0.0007797321,0.00018322482,0.06874089,0.48713982,0.00026325433],"about_ca_topic_score_codex":0.009387893,"about_ca_topic_score_gemma":0.015302546,"teacher_disagreement_score":0.022463875,"about_ca_system_score_codex":0.0055347476,"about_ca_system_score_gemma":0.00795079,"threshold_uncertainty_score":0.045434773},"labels":[],"label_agreement":null},{"id":"W2602746210","doi":"10.1177/2040622317700089","title":"Update on the management of giant cell arteritis","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Giant cell arteritis; Tocilizumab; Vasculitis; Dissection (medical); Ustekinumab; Stroke (engine); Intensive care medicine; Disease; Dermatology; Internal medicine; Surgery","score_opus":0.051626207491428454,"score_gpt":0.3780946341541366,"score_spread":0.32646842666270814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602746210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011655296,0.9977314,0.00008317678,0.0004091755,0.0003772112,0.000006222857,0.000035593253,0.000007571465,0.0012331909],"genre_scores_gemma":[0.0005211744,0.998126,0.00020879088,0.00035550108,0.0003556033,0.0000050352182,0.00005145919,0.000001492746,0.00037505754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997372,0.000054754953,0.000058032536,0.000032120515,0.00009660276,0.000021277003],"domain_scores_gemma":[0.9995241,0.0002255297,0.00008308651,0.000008953614,0.00012671947,0.000031640044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047949285,0.00063903973,0.0010567628,0.0022012838,0.00028622738,0.0010451787,0.0007258931,0.00095538184,0.006263922],"category_scores_gemma":[0.0011476623,0.00021189527,0.000669117,0.0016953996,0.00027332504,0.0011049644,0.00057602755,0.001673303,0.001894612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007124231,0.00007650557,0.00018684765,0.034636643,0.00013475995,0.00032430247,0.00011632101,0.0002790223,0.000943792,0.0023869548,0.06149984,0.8993437],"study_design_scores_gemma":[0.000019433808,0.00007029367,0.000641942,0.0117802555,0.00021150424,0.0019804582,0.00006386135,0.00006382676,0.00014471739,0.0009307536,0.98407793,0.000015141807],"about_ca_topic_score_codex":0.0011891372,"about_ca_topic_score_gemma":0.002275535,"teacher_disagreement_score":0.006263922,"about_ca_system_score_codex":0.0005089799,"about_ca_system_score_gemma":0.0012234971,"threshold_uncertainty_score":0.020954847},"labels":[],"label_agreement":null},{"id":"W2770769025","doi":"10.1177/2040622317742095","title":"Acute severe ulcerative colitis: latest evidence and therapeutic implications","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Infliximab; Fulminant; Colectomy; Toxic megacolon; Inflammatory bowel disease; Regimen; Internal medicine; Disease; Dosing; Intensive care medicine","score_opus":0.05679917040688162,"score_gpt":0.40085358684173333,"score_spread":0.3440544164348517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770769025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064495594,0.9985066,0.000042979107,0.00041791637,0.0002717703,0.000003026989,0.000019326088,0.000004825725,0.00066898606],"genre_scores_gemma":[0.00040779612,0.99878925,0.000081039434,0.00023282836,0.00022628348,0.00000335151,0.00003085956,0.0000011725613,0.00022753209],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997484,0.000044111443,0.000057143377,0.00004059181,0.000083195,0.000026561293],"domain_scores_gemma":[0.99926776,0.00033829312,0.00010195255,0.00002156201,0.00020667644,0.00006377187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006690615,0.0007052815,0.0013985869,0.0021011261,0.0003179192,0.0013788195,0.00089342514,0.00104447,0.0056378865],"category_scores_gemma":[0.0016783862,0.00023286816,0.000671242,0.0023876077,0.00048312204,0.0015497591,0.0007927782,0.0021249813,0.0022764825],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001137943,0.000047769427,0.0002747232,0.02449207,0.00012930851,0.00025799882,0.00006986762,0.00018066113,0.00052588683,0.002541797,0.043313134,0.928053],"study_design_scores_gemma":[0.00002510792,0.00006553557,0.00084120774,0.011324357,0.00022346496,0.001903684,0.000079591104,0.00004955109,0.00015610624,0.001929563,0.9833835,0.000018395116],"about_ca_topic_score_codex":0.00078904827,"about_ca_topic_score_gemma":0.0014909847,"teacher_disagreement_score":0.0056378865,"about_ca_system_score_codex":0.00064091955,"about_ca_system_score_gemma":0.0013795707,"threshold_uncertainty_score":0.018860579},"labels":[],"label_agreement":null},{"id":"W2790698850","doi":"10.1177/2040622318759282","title":"Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Dermira; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Eli Lilly and Company; Amgen","keywords":"Psoriasis; Medicine; Pathogenesis; Interleukin 23; Interleukin 17; Immunology; Immune system; Disease; Interleukin; Plaque psoriasis; Dermatology; Cytokine; Pathology","score_opus":0.013224506834935765,"score_gpt":0.28607260919385447,"score_spread":0.2728481023589187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790698850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009517182,0.9835383,0.0010653661,0.0028704053,0.00031969734,0.000017883245,0.00001944096,0.000021565509,0.0026300885],"genre_scores_gemma":[0.066613026,0.9265357,0.0019047826,0.0015146626,0.0010785279,0.000046685156,0.000039164734,0.000009486049,0.002257957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998776,0.00004098283,0.000012284863,0.000013232302,0.000032809785,0.000023136317],"domain_scores_gemma":[0.9999298,0.000020961143,0.000015411973,0.000002867321,0.000013786591,0.000017224054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004163847,0.00031492457,0.00045757496,0.0003738439,0.00017393543,0.00070252747,0.00020888867,0.00054690975,0.0009318321],"category_scores_gemma":[0.00017764787,0.00009512221,0.00020895162,0.0002646372,0.0003541901,0.00063767604,0.00028146512,0.001461128,0.00040072796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013035412,0.00046442015,0.0009844888,0.0030491203,0.00006977828,0.0012129581,0.00018502767,0.0007426376,0.0622431,0.013300394,0.01330156,0.903143],"study_design_scores_gemma":[0.0008326333,0.006981004,0.007975685,0.002481937,0.00040253956,0.013381151,0.0003951232,0.001734188,0.041469995,0.013215087,0.911038,0.000092798895],"about_ca_topic_score_codex":0.00021340458,"about_ca_topic_score_gemma":0.00064845604,"teacher_disagreement_score":0.0009318321,"about_ca_system_score_codex":0.00034786342,"about_ca_system_score_gemma":0.00039053368,"threshold_uncertainty_score":0.0031172633},"labels":[],"label_agreement":null},{"id":"W2807139522","doi":"10.1177/2040622318785575","title":"The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Stoneygate Trust; Kidney Research UK; National Institute for Health and Care Research","keywords":"Medicine; Kidney disease; Adverse effect; Physical therapy; Renal function; Meta-analysis; MEDLINE; Clinical trial; Internal medicine; Intensive care medicine","score_opus":0.054283871160306245,"score_gpt":0.42090521621378363,"score_spread":0.3666213450534774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807139522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009594603,0.9982692,0.00007744416,0.000112991685,0.000057609162,0.0001584815,0.00024160565,0.0000050465073,0.00011812508],"genre_scores_gemma":[0.01642627,0.98188764,0.00042588977,0.0003701753,0.00009985452,0.00046945465,0.00021133621,0.0000045339316,0.00010482384],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99335736,0.0019411327,0.0026649768,0.0006501633,0.0012050538,0.00018133431],"domain_scores_gemma":[0.9759805,0.016614608,0.0050428174,0.00029834025,0.0018207066,0.00024307017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061481358,0.0014147459,0.009784688,0.007377612,0.0006246209,0.0025503798,0.0016988898,0.0019368368,0.0031575465],"category_scores_gemma":[0.031254176,0.0010722787,0.008403945,0.008657243,0.0007705934,0.0018493402,0.0013180396,0.0011547887,0.00025231586],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017723403,0.000013369762,0.0014227722,0.9658581,0.014246291,0.000060609815,0.00010135898,0.000070023416,0.000092485585,0.000089652756,0.0008375585,0.017030638],"study_design_scores_gemma":[0.00033250914,0.00026669362,0.012208606,0.7808611,0.19170655,0.00048135375,0.00021854386,0.00015401944,0.00018963605,0.0003283571,0.013192721,0.000059817205],"about_ca_topic_score_codex":0.008164669,"about_ca_topic_score_gemma":0.021664897,"teacher_disagreement_score":0.009784688,"about_ca_system_score_codex":0.0024101187,"about_ca_system_score_gemma":0.008101183,"threshold_uncertainty_score":0.03251481},"labels":[],"label_agreement":null},{"id":"W2808614056","doi":"10.1177/2040622318781760","title":"Ustekinumab in psoriatic arthritis and related phenotypes","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Alberta","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Psoriasis; Immunology; Secukinumab; Clinical trial; Tumor necrosis factor alpha; Internal medicine; Infliximab","score_opus":0.024489282211767233,"score_gpt":0.3149809107407573,"score_spread":0.2904916285289901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808614056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016352545,0.9543316,0.0008094236,0.0026602189,0.0011170685,0.000046199704,0.00016539765,0.000127634,0.024390023],"genre_scores_gemma":[0.24713664,0.7218595,0.0018709578,0.0082351165,0.002843576,0.00011726336,0.00066937675,0.00003831003,0.017229242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998073,0.000051443873,0.000030919015,0.000020182055,0.00006369376,0.000026605476],"domain_scores_gemma":[0.99984574,0.000044710483,0.000039096416,0.000008947812,0.000032947708,0.000028529093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003194499,0.00028846008,0.0004926766,0.00043866172,0.00017273273,0.00044872265,0.00017153932,0.0005683836,0.0041579437],"category_scores_gemma":[0.00047325031,0.000076748256,0.00034174288,0.00051326817,0.00015310447,0.00028967796,0.00030824548,0.0011726962,0.0015587718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011603461,0.0002503376,0.0009664315,0.0030156348,0.00013560426,0.0010653252,0.00008309347,0.0002062033,0.009987167,0.0024538422,0.030885607,0.9497904],"study_design_scores_gemma":[0.001481076,0.0023426563,0.013228072,0.0022697253,0.0006056033,0.015973054,0.00014106269,0.0006426339,0.011225373,0.0050221747,0.94702315,0.000045327124],"about_ca_topic_score_codex":0.00044240485,"about_ca_topic_score_gemma":0.0010560976,"teacher_disagreement_score":0.0041579437,"about_ca_system_score_codex":0.00024167687,"about_ca_system_score_gemma":0.00026701117,"threshold_uncertainty_score":0.013909638},"labels":[],"label_agreement":null},{"id":"W2949196530","doi":"10.1177/2040622319854239","title":"Differential clusters of modifiable risk factors for impaired fasting glucose <i>versus</i> impaired glucose tolerance in adults 50 years of age and older","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Impaired fasting glucose; Impaired glucose tolerance; Medicine; Internal medicine; Body mass index; Diabetes mellitus; Triglyceride; Type 2 diabetes; Endocrinology; Cholesterol","score_opus":0.012338327200347207,"score_gpt":0.2658611835520159,"score_spread":0.25352285635166866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949196530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999193,0.0002769211,0.000046292025,0.000034786113,0.000007121625,0.0000046765504,0.00019048381,0.000002769153,0.0002439464],"genre_scores_gemma":[0.9994661,0.000075460055,0.00006726986,0.00002463213,0.000012654613,0.0000037777081,0.0002794882,0.0000010343855,0.0000697006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997764,0.00004169007,0.000026186894,0.00007030079,0.000033314638,0.00005195053],"domain_scores_gemma":[0.99936205,0.00009921164,0.00031656207,0.000054437834,0.000056830166,0.00011088734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041487598,0.00027604945,0.00042447937,0.00064083684,0.0003554259,0.00052926404,0.00022521634,0.0005042949,0.0011893128],"category_scores_gemma":[0.0012287585,0.0002225725,0.00051553734,0.0006455093,0.00024925487,0.0002564205,0.00038057452,0.00047404246,0.00015561348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083332976,0.000012882324,0.99905604,0.0000046132163,0.00003681397,0.00003336075,0.000033423163,0.000015264708,0.0001382328,0.000008513325,0.00003931966,0.0005382327],"study_design_scores_gemma":[0.000002357904,0.000023584134,0.9997764,0.000002186844,0.00001567827,0.00006147834,0.000037301874,0.000030871328,0.0000118925755,0.0000095234,0.000027773112,9.78676e-7],"about_ca_topic_score_codex":0.0060199853,"about_ca_topic_score_gemma":0.008985399,"teacher_disagreement_score":0.0060199853,"about_ca_system_score_codex":0.00018288117,"about_ca_system_score_gemma":0.00024914177,"threshold_uncertainty_score":0.011969864},"labels":[],"label_agreement":null},{"id":"W2980883173","doi":"10.1177/2040622319880392","title":"Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute for Dementia Research; National Health and Medical Research Council; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Disease; Dementia; Psychological intervention; Diabetes mellitus; Obesity; Risk factor; Environmental health; Stroke (engine); Public health; Risk assessment; Intensive care medicine; Gerontology; Pathology; Psychiatry","score_opus":0.09531433074301544,"score_gpt":0.40839082795910453,"score_spread":0.3130764972160891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980883173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008797826,0.9976312,0.00009023535,0.0012006679,0.00056584255,0.00005135717,0.00012842764,0.000006536222,0.00023765666],"genre_scores_gemma":[0.0027223218,0.994145,0.00037320895,0.0018924072,0.00036751188,0.00017680007,0.00010563902,0.000004833986,0.000212306],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98998624,0.0041600643,0.0025545643,0.00066460145,0.0023350497,0.00029950266],"domain_scores_gemma":[0.9601759,0.029974118,0.0055873343,0.0004710145,0.003497952,0.00029374874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010117609,0.0015412736,0.0044512567,0.0076137013,0.00052974146,0.0034316534,0.0015268015,0.002583772,0.0046788547],"category_scores_gemma":[0.061508298,0.0007608595,0.0043126396,0.010471655,0.00094096665,0.0029828148,0.0013107855,0.002260983,0.00059249846],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010779773,0.000012106179,0.00035514325,0.8721407,0.0034561842,0.00010020122,0.0003049477,0.00020762354,0.00015296896,0.0020939878,0.029840687,0.09122767],"study_design_scores_gemma":[0.00009469495,0.00005894194,0.0018586037,0.8507009,0.012107408,0.00025760772,0.00032692947,0.0001205979,0.00012042919,0.0019007903,0.13241711,0.000035925972],"about_ca_topic_score_codex":0.01219056,"about_ca_topic_score_gemma":0.03219573,"teacher_disagreement_score":0.01219056,"about_ca_system_score_codex":0.004565197,"about_ca_system_score_gemma":0.016964026,"threshold_uncertainty_score":0.053507626},"labels":[],"label_agreement":null},{"id":"W3082578667","doi":"10.1177/2040622320953352","title":"Carotid intima–media thickness relative to cognitive impairment in dialysis patients, and their relationship with brain volume and cerebral small vessel disease","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Science and Technology Program during the Twelfth Five-year Plan Period; Chinese Academy of Medical Sciences","keywords":"Medicine; Intima-media thickness; Internal medicine; Cardiology; Cognition; Atrophy; Brain size; Risk factor; Magnetic resonance imaging; Radiology; Psychiatry; Carotid arteries","score_opus":0.017307737815166587,"score_gpt":0.26558504770156066,"score_spread":0.24827730988639407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082578667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993812,0.00028102688,0.00003481726,0.000025887075,0.000003158055,0.0000025331003,0.000072020135,0.0000017534647,0.00019747137],"genre_scores_gemma":[0.9997979,0.00005511422,0.000037777176,0.0000070841897,0.000008187155,0.0000029437438,0.00004798646,4.9378815e-7,0.000042426735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997962,0.000048813137,0.00002644889,0.00003950868,0.000051960524,0.000037082627],"domain_scores_gemma":[0.9986345,0.00037929395,0.0005827685,0.000060538012,0.00010313843,0.00023981616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060462,0.00025251924,0.00025409655,0.0006325307,0.00032507148,0.00046997,0.0002199538,0.00032126284,0.0013025402],"category_scores_gemma":[0.0030930159,0.00016467903,0.00035550367,0.00066918595,0.00019645238,0.0002706316,0.00032067133,0.00070119277,0.00012424917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013717038,0.00003427651,0.9988424,0.0000063602597,0.000045450935,0.000044744622,0.00003328396,0.00003426971,0.000077628276,0.000006994211,0.00002268345,0.0007145892],"study_design_scores_gemma":[0.0000049870077,0.00007143774,0.99938893,0.0000028169475,0.000037630612,0.00016534307,0.000045103494,0.00018914005,0.00003368872,0.000023307959,0.000035834004,0.0000017788373],"about_ca_topic_score_codex":0.0018153819,"about_ca_topic_score_gemma":0.0016981191,"teacher_disagreement_score":0.0018153819,"about_ca_system_score_codex":0.00020826202,"about_ca_system_score_gemma":0.00027817997,"threshold_uncertainty_score":0.004357457},"labels":[],"label_agreement":null},{"id":"W3110182161","doi":"10.1177/2040622320968412","title":"Galectin-3 levels are elevated following nintedanib treatment","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nintedanib; Idiopathic pulmonary fibrosis; Medicine; Galectin-3; Pulmonary fibrosis; Fibrosis; Interstitial lung disease; In vivo; Lung; Internal medicine; Pathology; Biology","score_opus":0.03833303372186852,"score_gpt":0.31729001952852476,"score_spread":0.27895698580665623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110182161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797183,0.00084712426,0.00041238926,0.000059593596,0.000023467324,0.000014495863,0.00013942736,0.000023629604,0.0005081645],"genre_scores_gemma":[0.9986192,0.0002080888,0.00036338257,0.00005172858,0.000012718435,0.000016129517,0.000291858,0.0000028558557,0.00043402798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998385,0.00002878359,0.00001522821,0.000027466804,0.000046414923,0.0000436354],"domain_scores_gemma":[0.9998265,0.00003022021,0.000052018575,0.000010101383,0.00002404077,0.000057192825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001535031,0.0002605193,0.0003013277,0.00022869172,0.00016519282,0.00022736333,0.00008308676,0.0002780551,0.0017503076],"category_scores_gemma":[0.0001995344,0.00010422357,0.00024868967,0.0001139546,0.00024754705,0.000110164656,0.00014135742,0.0006214745,0.0001924384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015847051,0.00009970585,0.0057792785,0.00006111934,0.00002674645,0.0002345376,0.00003200954,0.000037198846,0.9898073,0.000013517497,0.00008000947,0.0022438825],"study_design_scores_gemma":[0.00015208624,0.0035479798,0.2050966,0.000015702528,0.00008738844,0.0019379313,0.00015082328,0.00074753107,0.7865265,0.000052443334,0.0016745235,0.0000105205745],"about_ca_topic_score_codex":0.00026971407,"about_ca_topic_score_gemma":0.0004423452,"teacher_disagreement_score":0.0017503076,"about_ca_system_score_codex":0.00020327594,"about_ca_system_score_gemma":0.00009155256,"threshold_uncertainty_score":0.0058553815},"labels":[],"label_agreement":null},{"id":"W3121762707","doi":"10.1177/2040622320982455","title":"Understanding racial differences of COPD patients with an ecological model: two large cohort studies in the US and Korea","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; COPD; Confidence interval; Exacerbation; Internal medicine; Cohort; Epidemiology; Cohort study; Quality of life (healthcare)","score_opus":0.08950860150498005,"score_gpt":0.3868383394179948,"score_spread":0.29732973791301476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121762707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884796,0.00022368444,0.00030926472,0.00010874098,0.000014549616,0.000041189505,0.00028715984,0.0000022240201,0.00016521921],"genre_scores_gemma":[0.9987748,0.00011732649,0.00039362352,0.000115401584,0.000010565074,0.00006793549,0.00043433186,0.0000038952935,0.00008209054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974275,0.0013254829,0.00022794136,0.0005130797,0.00019587115,0.0003100999],"domain_scores_gemma":[0.99609756,0.0007445782,0.0010721288,0.0009972461,0.0005529846,0.0005354296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006253589,0.0007386495,0.000557364,0.0012387884,0.0015851416,0.0015001498,0.0011029951,0.0009693557,0.001012478],"category_scores_gemma":[0.00755374,0.0007349706,0.002192851,0.0015790886,0.0007971525,0.0012827361,0.0019146367,0.0011760236,0.00018482615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001823597,0.000096001815,0.99776626,0.00001262295,0.0003103845,0.000068117435,0.0005774291,0.00003510755,0.00007644981,0.00006621179,0.00015684046,0.00065216457],"study_design_scores_gemma":[0.00005504131,0.0001489677,0.99568534,0.000033303215,0.0003882734,0.00020107657,0.0021667676,0.00070862536,0.00004767755,0.0001310672,0.000415152,0.000018597633],"about_ca_topic_score_codex":0.031646382,"about_ca_topic_score_gemma":0.03931423,"teacher_disagreement_score":0.031646382,"about_ca_system_score_codex":0.00092780654,"about_ca_system_score_gemma":0.0013056676,"threshold_uncertainty_score":0.062924325},"labels":[],"label_agreement":null},{"id":"W3163973934","doi":"10.1177/20406223211015958","title":"A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Cancer survivorship and care","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of Alberta","funders":"Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; University of Birmingham; Kidney Foundation of Canada; UK Research and Innovation; Birmingham Biomedical Research Centre; University Hospitals Birmingham NHS Foundation Trust","keywords":"Medicine; Telemedicine; Patient-reported outcome; Narrative review; Relevance (law); Health care; MEDLINE; Quality of life (healthcare); Intensive care medicine; Nursing","score_opus":0.09966992441523867,"score_gpt":0.48316707914714296,"score_spread":0.38349715473190427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163973934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009772262,0.99893826,0.00007217554,0.00024126984,0.00011083926,0.000051234376,0.000098258846,0.000003867622,0.00038629796],"genre_scores_gemma":[0.0011035157,0.9981608,0.00021110254,0.00024138711,0.00006236336,0.00007755814,0.00007266235,0.0000015658122,0.0000690052],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625504,0.0013222327,0.001283908,0.0002796201,0.0007531434,0.0001059413],"domain_scores_gemma":[0.97771263,0.017664732,0.002708118,0.00021950582,0.0015381731,0.00015696383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048222626,0.0012346562,0.003425153,0.0073923,0.00044989126,0.002264335,0.0015884753,0.0015138015,0.007563445],"category_scores_gemma":[0.028645676,0.00048621482,0.0030592184,0.009293912,0.0006051055,0.0018476519,0.0011551011,0.0013258765,0.0008693447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011958824,0.000023033008,0.00027413626,0.78210473,0.0011133362,0.00012913406,0.00018537191,0.00015351172,0.00014793662,0.0010975206,0.008395937,0.20625581],"study_design_scores_gemma":[0.000054961754,0.00011440187,0.0017566705,0.83914006,0.0063592824,0.00059327285,0.00018517477,0.00006871478,0.00011776475,0.00070752116,0.15087573,0.000026395921],"about_ca_topic_score_codex":0.0035863773,"about_ca_topic_score_gemma":0.008453661,"teacher_disagreement_score":0.007563445,"about_ca_system_score_codex":0.0018795414,"about_ca_system_score_gemma":0.007932367,"threshold_uncertainty_score":0.02550292},"labels":[],"label_agreement":null},{"id":"W3180821427","doi":"10.1177/20406223211026178","title":"Are muscle weakness and stiffness risk factors of the development of rotator cuff tendinopathy in overhead athletes: a systematic review","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rotator cuff; Weakness; Tendinopathy; Muscle weakness; Physical therapy; Physical medicine and rehabilitation; Range of motion; Risk factor; Tendon; Internal medicine; Surgery","score_opus":0.05153118163316191,"score_gpt":0.38019195907630826,"score_spread":0.32866077744314637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180821427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025059711,0.9961105,0.00013138214,0.00030122156,0.000094370735,0.00015003039,0.0005073106,0.0000072361,0.0001920322],"genre_scores_gemma":[0.05032534,0.94693464,0.0007366639,0.0007317691,0.00011579201,0.00053224363,0.00048591357,0.00000868899,0.00012901504],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9916003,0.0024492885,0.0037215266,0.000739032,0.0012465232,0.00024340062],"domain_scores_gemma":[0.95758027,0.029102465,0.009578226,0.0006212094,0.0027824563,0.00033540974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074447,0.0010777643,0.007595349,0.007862414,0.00054297724,0.0026556156,0.001941815,0.0024418996,0.0029448115],"category_scores_gemma":[0.0463375,0.001322135,0.009653249,0.007822093,0.00089873705,0.0021607906,0.0012294574,0.0010216812,0.0002579373],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016338928,0.000011914158,0.0038032397,0.9568902,0.01922243,0.000106599255,0.00019739039,0.00007837934,0.00009563116,0.00012254997,0.0009314339,0.018376824],"study_design_scores_gemma":[0.00024061697,0.00017854621,0.017251452,0.8421726,0.12959526,0.0005803494,0.00028632194,0.000117428935,0.00014144629,0.00026841278,0.009118335,0.00004907123],"about_ca_topic_score_codex":0.012381289,"about_ca_topic_score_gemma":0.030646445,"teacher_disagreement_score":0.012381289,"about_ca_system_score_codex":0.0026825517,"about_ca_system_score_gemma":0.008993673,"threshold_uncertainty_score":0.03937179},"labels":[],"label_agreement":null},{"id":"W3202344016","doi":"10.1177/20406223211046999","title":"Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"Capital Health Research and Development of Special Fund","keywords":"Medicine; Stroke (engine); Myocardial infarction; Percutaneous coronary intervention; Mace; Conventional PCI; Internal medicine; Clinical endpoint; Confounding; Medical prescription; Population; Cardiology; Clinical trial","score_opus":0.01633609413278083,"score_gpt":0.32967738813427266,"score_spread":0.31334129400149185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202344016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923855,0.0039958498,0.0002010488,0.00043798704,0.000020032581,0.00005023115,0.0010660441,0.000006742442,0.0018364656],"genre_scores_gemma":[0.99716103,0.0012605469,0.00042618663,0.000094701994,0.0000672063,0.000034563283,0.00087930635,0.0000012712434,0.00007533112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987801,0.00038012094,0.00039087667,0.00010858767,0.0002613308,0.00007901587],"domain_scores_gemma":[0.9962136,0.00088593777,0.0022406403,0.00010040651,0.00027700322,0.0002823053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011500579,0.00017356449,0.00067078864,0.0016194092,0.00026495632,0.000623837,0.0002813747,0.0003151883,0.0011490887],"category_scores_gemma":[0.0071147494,0.00011598756,0.00042868446,0.0015489387,0.00017733901,0.00043472706,0.0003421401,0.00034568188,0.00018177307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022728587,0.000049838927,0.9931678,0.00008460143,0.00006464859,0.000082142295,0.000031958207,0.000032897162,0.000046163153,0.000019004585,0.00019836726,0.005995297],"study_design_scores_gemma":[0.000026686846,0.00014253557,0.9984906,0.000053101892,0.0000735759,0.00039156544,0.000089738794,0.00024314474,0.000057500183,0.00005833353,0.0003694961,0.0000037562183],"about_ca_topic_score_codex":0.0014782329,"about_ca_topic_score_gemma":0.0023247832,"teacher_disagreement_score":0.0016194092,"about_ca_system_score_codex":0.00039561893,"about_ca_system_score_gemma":0.00057916605,"threshold_uncertainty_score":0.006082177},"labels":[],"label_agreement":null},{"id":"W4214487187","doi":"10.1177/20406223221079246","title":"Multiple endocrine neoplasia 2: an overview","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Multiple endocrine neoplasia type 2; Endocrine system; Multiple endocrine neoplasia; Intensive care medicine; Internal medicine; Hormone; Germline mutation; Mutation","score_opus":0.13048629318708846,"score_gpt":0.46193053580649596,"score_spread":0.3314442426194075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214487187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013634388,0.9974287,0.00012286249,0.00031199396,0.0002919199,0.0000054569077,0.00004149368,0.000012220964,0.0016489489],"genre_scores_gemma":[0.00051985355,0.998069,0.00021093844,0.00025363622,0.00025918838,0.000005729391,0.00007140308,0.0000017170755,0.0006086012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998745,0.000019048352,0.000023015647,0.000022490038,0.000048343383,0.000012593698],"domain_scores_gemma":[0.9998203,0.000087230976,0.000026951117,0.000004047472,0.00004277929,0.000018704864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029022034,0.0006638868,0.0008309805,0.0023395848,0.0002405426,0.0007521958,0.00045570018,0.0006216902,0.005437826],"category_scores_gemma":[0.0005261362,0.00019479828,0.00041216207,0.001715377,0.00017211473,0.0010419814,0.00049679185,0.0012294134,0.002237357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059279853,0.00004744673,0.00031314004,0.015845062,0.00008429723,0.00045334495,0.00006640599,0.00022522542,0.0010424532,0.001633973,0.0467542,0.93347526],"study_design_scores_gemma":[0.000012616566,0.00006199707,0.00087235984,0.0049095056,0.00012481972,0.0043439907,0.000057432535,0.000058436082,0.00019848788,0.0009338362,0.9884116,0.0000149341695],"about_ca_topic_score_codex":0.00087049516,"about_ca_topic_score_gemma":0.0016685757,"teacher_disagreement_score":0.005437826,"about_ca_system_score_codex":0.00037619832,"about_ca_system_score_gemma":0.00084398116,"threshold_uncertainty_score":0.018191338},"labels":[],"label_agreement":null},{"id":"W4225810571","doi":"10.1177/20406223221080646","title":"Effectiveness of using calligraphic activity to treat people with schizophrenia: a randomized controlled trial in Southern Taiwan","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Mood; Schizophrenia (object-oriented programming); Medicine; Positive and Negative Syndrome Scale; Cognition; Quality of life (healthcare); Anxiety; Visual analogue scale; Clinical psychology; Psychiatry; Physical therapy; Internal medicine; Psychosis","score_opus":0.018603833684819673,"score_gpt":0.3468946723059099,"score_spread":0.32829083862109026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225810571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035966,0.0038455103,0.0002864607,0.00061364315,0.00021297029,0.0038329116,0.00025826535,0.00006341154,0.00052718195],"genre_scores_gemma":[0.9889992,0.0024282434,0.0008205594,0.00065267395,0.0001938365,0.005895429,0.0002610762,0.000005519819,0.0007435613],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990325,0.0005229321,0.00012167948,0.00013231619,0.000052017578,0.00013851619],"domain_scores_gemma":[0.99905103,0.00018802291,0.00024534226,0.000059093887,0.000062174084,0.00039435262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017553671,0.0008503927,0.0021104007,0.0006966913,0.0005884397,0.00061465235,0.0006365539,0.0015475693,0.004187389],"category_scores_gemma":[0.0019845585,0.0004729234,0.0019285703,0.00063178426,0.0009793745,0.00059745234,0.0005245306,0.0013015269,0.00024165247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9519466,0.012055751,0.0027571502,0.0021904793,0.0019568237,0.00011455846,0.0001482016,0.00031854617,0.0016360848,0.000068904505,0.00037453353,0.02643225],"study_design_scores_gemma":[0.9364165,0.055600278,0.0059707873,0.00011058773,0.0011443953,0.000017491231,0.000074187476,0.00025036224,0.00015230096,0.000046340232,0.00020341555,0.000013375254],"about_ca_topic_score_codex":0.006186959,"about_ca_topic_score_gemma":0.011713284,"teacher_disagreement_score":0.006186959,"about_ca_system_score_codex":0.0011188383,"about_ca_system_score_gemma":0.002600845,"threshold_uncertainty_score":0.014008164},"labels":[],"label_agreement":null},{"id":"W4309664035","doi":"10.1177/20406223221137499","title":"Strongyloidiasis: what every gastroenterologist needs to know","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Manitoba; Public Health Ontario; University of Toronto; McMaster University","funders":"University of Toronto; University Health Network","keywords":"Strongyloidiasis; Strongyloides stercoralis; Medicine; Asymptomatic; Disease; Parasitic disease; Immunology; Intensive care medicine; Gastroenterology; Internal medicine; Helminths","score_opus":0.04300917368829776,"score_gpt":0.3843205422372391,"score_spread":0.34131136854894134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309664035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018867961,0.9773432,0.00027294262,0.016067076,0.0038986811,0.000008348978,0.00003673694,0.000026462465,0.0021578846],"genre_scores_gemma":[0.0013177702,0.9841659,0.0005056371,0.006535046,0.005554259,0.000011199278,0.000081144404,0.0000062176455,0.0018228586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997209,0.00007303524,0.00003715782,0.000035675454,0.00010358893,0.000029649982],"domain_scores_gemma":[0.9990489,0.00046979322,0.00009982515,0.000033655906,0.00021818565,0.00012960735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006489408,0.0006328506,0.0013779354,0.0011680519,0.0004976504,0.0017394588,0.00071847194,0.0023869777,0.004621459],"category_scores_gemma":[0.0019070122,0.00026482475,0.0005025414,0.00087382295,0.0008779053,0.00526406,0.00073946617,0.0037262798,0.0028409397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008093609,0.00007103518,0.0006009806,0.01021821,0.000058274174,0.0008860078,0.00018746126,0.00014915215,0.00076274807,0.003025128,0.19964409,0.784316],"study_design_scores_gemma":[0.000013342763,0.000051967378,0.0011920491,0.007063679,0.000038064696,0.0047032866,0.00032430617,0.00006105514,0.00010812036,0.0041084024,0.9823062,0.000029555838],"about_ca_topic_score_codex":0.0019024677,"about_ca_topic_score_gemma":0.002833032,"teacher_disagreement_score":0.004621459,"about_ca_system_score_codex":0.00051440886,"about_ca_system_score_gemma":0.0012503267,"threshold_uncertainty_score":0.015460253},"labels":[],"label_agreement":null},{"id":"W4362570802","doi":"10.1177/20406223231164523","title":"The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Fatty liver; Position statement; Disease; Association (psychology); Internal medicine; Family medicine; Psychology; Psychotherapist","score_opus":0.028942501269459,"score_gpt":0.3083053368495036,"score_spread":0.2793628355800446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362570802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016620915,0.12468404,0.008823792,0.691704,0.105383456,0.00016695909,0.0021117183,0.00014556987,0.06531848],"genre_scores_gemma":[0.042446584,0.21908805,0.071621396,0.4937904,0.11584859,0.0017559818,0.0075117233,0.00042129355,0.04751598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157846,0.0020912315,0.0016112705,0.0006094145,0.003218628,0.0008910818],"domain_scores_gemma":[0.9766153,0.0069565414,0.0026354063,0.0007280561,0.00971298,0.0033517117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014240929,0.0013763221,0.0016237855,0.0032391315,0.0022488248,0.0048541753,0.0030213746,0.0074307914,0.0058508036],"category_scores_gemma":[0.030940266,0.00063957745,0.0025110347,0.0029632542,0.004677747,0.0030293611,0.006185247,0.020802815,0.0035917608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010501911,0.00008141542,0.003252444,0.0010080504,0.00008135132,0.00058128353,0.00041201626,0.00028748947,0.0005090158,0.06398966,0.8198719,0.10982028],"study_design_scores_gemma":[0.000043385095,0.00007584528,0.0042780535,0.004096247,0.00007490091,0.0017441005,0.00031149545,0.00014470571,0.00039156896,0.013505265,0.97528005,0.000054375654],"about_ca_topic_score_codex":0.013300307,"about_ca_topic_score_gemma":0.014281364,"teacher_disagreement_score":0.014240929,"about_ca_system_score_codex":0.004089157,"about_ca_system_score_gemma":0.022259168,"threshold_uncertainty_score":0.075314164},"labels":[],"label_agreement":null},{"id":"W4376612893","doi":"10.1177/20406223231169715","title":"Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"GlaxoSmithKline; National Institutes of Health; Novartis Pharmaceuticals Corporation; Pfizer; U.S. Department of Health and Human Services","keywords":"Medicine; Osteoarthritis; WOMAC; Incidence (geometry); Proportional hazards model; Population; Physical therapy; Cohort; Knee pain; Cohort study; Hazard ratio; Surgery; Internal medicine; Confidence interval; Pathology","score_opus":0.009279524260799555,"score_gpt":0.3166213819825064,"score_spread":0.30734185772170686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376612893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929589,0.005300575,0.00019026127,0.00039780096,0.000028415825,0.000014239702,0.0003753904,0.000006527498,0.0007278861],"genre_scores_gemma":[0.99870193,0.000727267,0.0001275393,0.000035823374,0.00004260188,0.0000062433974,0.00021765297,0.0000018336817,0.00013915382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994916,0.0001539082,0.000068750196,0.0000903364,0.00011399504,0.00008139342],"domain_scores_gemma":[0.9960991,0.0007084086,0.0020134468,0.00020786733,0.0003365651,0.0006346129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011198955,0.00035504205,0.00033722405,0.0006464774,0.00036589825,0.0007500041,0.0005057197,0.0006343473,0.0022805321],"category_scores_gemma":[0.0054470454,0.00020733358,0.0006642564,0.00084066263,0.00034581008,0.0005206242,0.00047544396,0.0006813185,0.00022277505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006988724,0.000024866218,0.9981925,0.000019019535,0.0000651258,0.000027047632,0.000033179487,0.000017993087,0.000041138966,0.000012390102,0.000050240196,0.0014466528],"study_design_scores_gemma":[0.0000020540379,0.000051219384,0.99956733,0.000014672304,0.00003489982,0.0000769911,0.00006194142,0.0000896684,0.000008731288,0.000020585729,0.0000702134,0.0000016887485],"about_ca_topic_score_codex":0.0062380773,"about_ca_topic_score_gemma":0.0096192965,"teacher_disagreement_score":0.0062380773,"about_ca_system_score_codex":0.00019588263,"about_ca_system_score_gemma":0.0004897591,"threshold_uncertainty_score":0.012403548},"labels":[],"label_agreement":null},{"id":"W4380322953","doi":"10.1177/20406223231173624","title":"Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Trinity Western University; Centre for Advancing Health Outcomes; Western University; University of Victoria; University of Calgary; McGill University; Jewish General Hospital; University of Alberta","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Medicine; Thematic analysis; Focus group; Longitudinal study; Qualitative research; Family medicine; Nursing; Medical education","score_opus":0.05077915116653597,"score_gpt":0.4696836066526721,"score_spread":0.41890445548613614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380322953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788817,0.0006098763,0.0028429595,0.0010675235,0.00006247932,0.013674136,0.00034635427,0.000059733433,0.0024552783],"genre_scores_gemma":[0.9470087,0.0007866922,0.027142402,0.00036601856,0.00006277673,0.0238709,0.0002972403,0.000019586472,0.00044570144],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8691801,0.10846128,0.00806827,0.0021187102,0.009501207,0.002670421],"domain_scores_gemma":[0.8144607,0.12951598,0.025947014,0.0056652776,0.017426565,0.0069844783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12428928,0.00083121966,0.0012264234,0.0022096427,0.0016373611,0.0032680735,0.0016269649,0.0013194355,0.0013890141],"category_scores_gemma":[0.17370228,0.00058857346,0.0015025209,0.0024203311,0.0017234103,0.0031040274,0.005153144,0.0017714975,0.00018407656],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020501183,0.041543353,0.1441149,0.0068075494,0.00067086937,0.00022099202,0.06855431,0.002363948,0.001542536,0.0017834334,0.0017923595,0.7101045],"study_design_scores_gemma":[0.037650593,0.22839417,0.5326152,0.009513471,0.002897292,0.0005030857,0.119461365,0.020113762,0.016781114,0.004698407,0.02662892,0.0007427284],"about_ca_topic_score_codex":0.002578455,"about_ca_topic_score_gemma":0.0034407123,"teacher_disagreement_score":0.12428928,"about_ca_system_score_codex":0.0068338313,"about_ca_system_score_gemma":0.015016644,"threshold_uncertainty_score":0.6573124},"labels":[],"label_agreement":null},{"id":"W4388799386","doi":"10.1177/20406223231209329","title":"The emerging role of digital health in the management of asthma","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Université Laval; Barrie Urology Group; University of Toronto","funders":"Sanofi Genzyme; Moderna; Canadian Institutes of Health Research; Covis Pharma; Teva Pharmaceutical Industries; Novo Nordisk; Eisai; Sanofi; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Asthma; Inhaler; Medicine; Digital health; Control (management); Asthma management; Disease management; Health care; Intensive care medicine; Alternative medicine; Computer science; Health management system","score_opus":0.0778241805147946,"score_gpt":0.5098606123577395,"score_spread":0.4320364318429449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388799386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010707878,0.9976997,0.00010152557,0.00047166925,0.00017695839,0.000008424808,0.000012852387,0.00000659864,0.0014152589],"genre_scores_gemma":[0.00086686213,0.9981073,0.00020889413,0.00040319902,0.00014828502,0.000008897703,0.000014045067,0.0000013902919,0.00024109166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993268,0.00020370986,0.00008914528,0.00007969409,0.00023881644,0.00006185652],"domain_scores_gemma":[0.9974306,0.0019277171,0.0002051462,0.000048302365,0.00028825022,0.00010002176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014990489,0.00067617977,0.0013286107,0.0030064604,0.0004643657,0.0020316713,0.00078731583,0.0020270129,0.0067698443],"category_scores_gemma":[0.0025726294,0.00027482805,0.0010783713,0.0034825176,0.0009785491,0.0027338162,0.0013493623,0.0028541961,0.0014187003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003344834,0.00005082865,0.00014810608,0.039496303,0.000101992184,0.00008411767,0.00016156654,0.00015704268,0.00044879256,0.006712954,0.0112544345,0.9413505],"study_design_scores_gemma":[0.00002585387,0.00013130467,0.0015889496,0.028074246,0.00026705168,0.0009782865,0.00027549543,0.00013035904,0.00025453663,0.0045117377,0.9637326,0.000029609542],"about_ca_topic_score_codex":0.0023169222,"about_ca_topic_score_gemma":0.0033398343,"teacher_disagreement_score":0.0067698443,"about_ca_system_score_codex":0.0009179736,"about_ca_system_score_gemma":0.0024206191,"threshold_uncertainty_score":0.02264738},"labels":[],"label_agreement":null},{"id":"W4389318303","doi":"10.1177/20406223231213246","title":"Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jiangsu Commission of Health","keywords":"Medicine; Albuminuria; Hazard ratio; Internal medicine; Klotho; Meta-analysis; Renal function; Kidney disease; Odds ratio; Creatinine; Biomarker; Diabetes mellitus; Urology; Kidney; Confidence interval; Endocrinology","score_opus":0.07585031665300866,"score_gpt":0.44109306526983977,"score_spread":0.3652427486168311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389318303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01284265,0.9827838,0.0024150526,0.00036303067,0.00033620864,0.00030159598,0.0006116616,0.000061829065,0.00028424768],"genre_scores_gemma":[0.6057616,0.38050422,0.006902757,0.0014911903,0.0007962679,0.0018508648,0.0020027205,0.00013372795,0.0005567627],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9759769,0.013529589,0.0055156834,0.0025035508,0.0019317605,0.00054249197],"domain_scores_gemma":[0.9516545,0.037966266,0.005312452,0.0023642306,0.002166269,0.0005362373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035675697,0.004163062,0.02172969,0.010218213,0.0008579534,0.005013021,0.0031986984,0.0029134841,0.0025309043],"category_scores_gemma":[0.052493077,0.0019367582,0.07634058,0.009830784,0.00086395396,0.002410582,0.002400711,0.0026539809,0.0003042853],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013832801,0.000012135491,0.00734247,0.031013545,0.956829,0.00006543126,0.000024729308,0.00041402824,0.000109351255,0.000045736182,0.00012815585,0.0026322182],"study_design_scores_gemma":[0.0001980489,0.00007828725,0.0026864028,0.0017672498,0.9945201,0.00003572873,0.000013554762,0.00022898697,0.000050696286,0.00013049063,0.00027983042,0.000010584404],"about_ca_topic_score_codex":0.004123863,"about_ca_topic_score_gemma":0.0065550953,"teacher_disagreement_score":0.035675697,"about_ca_system_score_codex":0.0021204362,"about_ca_system_score_gemma":0.002513788,"threshold_uncertainty_score":0.18867332},"labels":[],"label_agreement":null},{"id":"W4393360017","doi":"10.1177/20406223241239168","title":"Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute; University of Manitoba; University of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Dalhousie University; Institut de Cardiologie de Montréal; Allergan; Queen's University; McMaster University; Research Manitoba; Takeda Pharmaceutical Company; University of Alberta; Alberta Innovates; University of Calgary","keywords":"Medicine; Ulcerative colitis; Context (archaeology); Preference; Latent class model; Pill; Internal medicine; Logistic regression; Fecal bacteriotherapy; Disease","score_opus":0.02643301619419966,"score_gpt":0.35274260675734354,"score_spread":0.3263095905631439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393360017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747,0.00015826177,0.00017150996,0.00062323443,0.0000039596184,0.000024830313,0.00016497726,0.0000019725583,0.001381291],"genre_scores_gemma":[0.9994659,0.000057142217,0.00018070046,0.00010744771,0.0000028464958,0.0000075368653,0.0000706443,4.948766e-7,0.00010717753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848866,0.00073476863,0.00012052503,0.00009519905,0.00034178715,0.000218993],"domain_scores_gemma":[0.9943001,0.0030843085,0.001491728,0.00011900212,0.00029431126,0.0007105565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021517742,0.00013280922,0.0002110965,0.00032368943,0.00052669796,0.0009495233,0.0001716586,0.0005799223,0.006590752],"category_scores_gemma":[0.009068842,0.00007648684,0.0006530082,0.00050909945,0.00045778172,0.00041403522,0.00035786696,0.000662424,0.0002213634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096908666,0.0004382246,0.9692796,0.00013960285,0.00017651376,0.00019830538,0.0016247282,0.00094072014,0.0006262338,0.00040078754,0.00090957864,0.024296686],"study_design_scores_gemma":[0.000102591344,0.0009037708,0.9856231,0.00013661812,0.00010906834,0.00065688114,0.005510935,0.0033817585,0.00037187725,0.0007223164,0.0024347869,0.00004645561],"about_ca_topic_score_codex":0.017437125,"about_ca_topic_score_gemma":0.030070206,"teacher_disagreement_score":0.017437125,"about_ca_system_score_codex":0.0014418846,"about_ca_system_score_gemma":0.0016202342,"threshold_uncertainty_score":0.034671247},"labels":[],"label_agreement":null},{"id":"W4404821936","doi":"10.1177/20406223241302707","title":"Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Chronic Disease","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cementum; Medicine; Periodontal fiber; Regeneration (biology); Gingival recession; Dentistry; Dental alveolus; Wound healing; Surgery; Dentin; Biology","score_opus":0.34161806403929285,"score_gpt":0.48471071320300074,"score_spread":0.1430926491637079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404821936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069685906,0.9986009,0.00005542065,0.00025612174,0.00032185338,0.0000074635227,0.000037432532,0.00000585803,0.000645203],"genre_scores_gemma":[0.0003181669,0.99877936,0.0001595944,0.00022094988,0.00017693952,0.000007805455,0.00005631613,0.0000014521801,0.00027939206],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996196,0.00006433073,0.00010676083,0.000048806192,0.00013683585,0.000023645875],"domain_scores_gemma":[0.99892104,0.00061386393,0.00014533671,0.000024442072,0.00024881843,0.000046703466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009579933,0.00075100927,0.0015595566,0.0037366007,0.00024543665,0.0011459979,0.0007981939,0.0010390453,0.007054487],"category_scores_gemma":[0.0018923698,0.00032273543,0.0011323608,0.0033984338,0.00031596274,0.0014474721,0.00055898796,0.0014800605,0.0018706645],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014348392,0.00006966223,0.00019495768,0.08493761,0.00024830768,0.00026589906,0.000095290285,0.00015075007,0.0014899506,0.0020246028,0.056853246,0.8535262],"study_design_scores_gemma":[0.000031410487,0.000106525935,0.00086534716,0.015043139,0.0005582614,0.0012999856,0.00006385351,0.0000507378,0.0003096109,0.00075990555,0.98089063,0.00002058316],"about_ca_topic_score_codex":0.0012536275,"about_ca_topic_score_gemma":0.0023073491,"teacher_disagreement_score":0.007054487,"about_ca_system_score_codex":0.00053219125,"about_ca_system_score_gemma":0.0016626702,"threshold_uncertainty_score":0.023599565},"labels":[],"label_agreement":null}]}